litlas
ログインアカウント作成

Melinda E. Sanders

2002–2025 年に発表

89
論文数
26,852
被引用数
63
h 指数
86
i10 指数

被引用数

Melinda E. Sanders の年別被引用数1945 年: 被引用 1 件1974 年: 被引用 1 件1984 年: 被引用 1 件1996 年: 被引用 1 件1999 年: 被引用 1 件2001 年: 被引用 1 件2002 年: 被引用 1 件2003 年: 被引用 5 件2004 年: 被引用 15 件2005 年: 被引用 19 件2006 年: 被引用 31 件2007 年: 被引用 27 件2008 年: 被引用 39 件2009 年: 被引用 22 件2010 年: 被引用 45 件2011 年: 被引用 44 件2012 年: 被引用 51 件2013 年: 被引用 101 件2014 年: 被引用 125 件2015 年: 被引用 206 件2016 年: 被引用 226 件2017 年: 被引用 313 件2018 年: 被引用 415 件2019 年: 被引用 1,269 件2020 年: 被引用 1,589 件2021 年: 被引用 1,702 件2022 年: 被引用 1,411 件2023 年: 被引用 1,076 件2024 年: 被引用 1,475 件2025 年: 被引用 802 件2026 年: 被引用 26 件1946〜1973 年は被引用が無いため表示していません1975〜1983 年は被引用が無いため表示していません1985〜1995 年は被引用が無いため表示していません1997〜1998 年は被引用が無いため表示していません2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,748 件、この内訳の 25.9%中国: 引用元論文 2,659 件、この内訳の 18.4%イタリア: 引用元論文 654 件、この内訳の 4.5%イギリス: 引用元論文 650 件、この内訳の 4.5%ドイツ: 引用元論文 568 件、この内訳の 3.9%フランス: 引用元論文 468 件、この内訳の 3.2%カナダ: 引用元論文 393 件、この内訳の 2.7%オーストラリア: 引用元論文 372 件、この内訳の 2.6%スペイン: 引用元論文 347 件、この内訳の 2.4%韓国: 引用元論文 336 件、この内訳の 2.3%インド: 引用元論文 325 件、この内訳の 2.3%日本: 引用元論文 319 件、この内訳の 2.2%
0%25.9%その他 25.1%

機関

分野

  • Medicine44.8%
  • Biochemistry, Genetics and Molecular Biology41.1%
  • Immunology and Microbiology4.9%
  • Chemistry3.3%
  • Engineering1.8%
  • Computer Science1.6%
  • その他2.5%

トピック

  • Cancer Immunotherapy and Biomarkers6.2%
  • Cancer Cells and Metastasis4.3%
  • Breast Cancer Treatment Studies3.7%
  • Cancer Genomics and Diagnostics3.3%
  • Immunotherapy and Immune Responses2.8%
  • Advanced Breast Cancer Therapies2.6%
  • その他77.1%

共著者

全論文

検索で開く
  1. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

    著者: Brian D. Lehmann, Joshua A. Bauer, Xi Chen, Melinda E. Sanders, A. Bapsi Chakravarthy, Yu Shyr, Jennifer A. Pietenpol - Journal of Clinical Investigation 2011 被引用: 5,515

  2. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

    著者: Giampaolo Bianchini, Justin M. Balko, Ingrid A. Mayer, Melinda E. Sanders, Luca Gianni - Nature Reviews Clinical Oncology 2016 被引用: 3,072

  3. Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data

    著者: Francesca Finotello, Clemens Mayer, Christina Plattner, Gerhard Laschober, Dietmar Rieder, Hubert Hackl, Anne Krogsdam, Zuzana Loncová, Wilfried Posch, Doris Wilflingseder, Sieghart Sopper, Marieke E. Ijsselsteijn, Thomas P. Brouwer, Douglas B. Johnson, Yaomin Xu, Yu Wang, Melinda E. Sanders, Mónica V. Estrada, Paula I. González-Ericsson, Pornpimol Charoentong, Justin M. Balko, Noel F.C.C. de Miranda, Zlatko Trajanoski - Genome Medicine 2019 被引用: 1,681

  4. Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection

    著者: Brian D. Lehmann, Bojana Jovanović, Xi Chen, Mónica V. Estrada, Kimberly N. Johnson, Yu Shyr, Harold L. Moses, Melinda E. Sanders, Jennifer A. Pietenpol - PLoS ONE 2016 被引用: 1,409

  5. Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities

    著者: Suhas Vasaikar, Chen Huang, Xiaojing Wang, Vladislav Petyuk, Sara R. Savage, Bo Wen, Yongchao Dou, Yun Zhang, Zhiao Shi, Osama A. Arshad, Marina A. Gritsenko, Lisa J. Zimmerman, Jason McDermott, Therese RW Clauss, Ronald Moore, Rui Zhao, Matthew Monroe, Yi-Ting Wang, Matthew Chambers, Robbert J.C. Slebos, Ken S. Lau, Qianxing Mo, Li Ding, Matthew J. Ellis, Mathangi Thiagarajan, Christopher R. Kinsinger, Henry Rodriguez, Richard Smith, Karin Rodland, D.C. Liebler, Tao Liu, Bing Zhang, Akhilesh Pandey, Amanda G. Paulovich, Andrew N. Hoofnagle, D.R. Mani, Daniel W. Chan, David F. Ransohoff, David Fenyö, David L. Tabb, Douglas A. Levine, Emily S. Boja, Eric Kuhn, Forest M. White, Gordon A. Whiteley, Heng Zhu, Hui Zhang, Ie‐Ming Shih, Jasmin Bavarva, Jeffrey R. Whiteaker, Karen A. Ketchum, Karl R. Clauser, Kelly V. Ruggles, Kimberly Elburn, Linda I. Hannick, Mark A. Watson, Mauricio Oberti, Mehdi Mesri, Melinda E. Sanders, Melissa Borucki, Michael A. Gillette, M Snyder, Nathan Edwards, Negin Vatanian, Paul A. Rudnick, Peter B. McGarvey, Philip Mertins, R. Reid Townsend, Ratna R. Thangudu, Robert Rivers, Samuel Payne, Sherri R. Davies, Shuang Cai, Stephen E. Stein, Steven A. Carr, Steven J. Skates, Subha Madhavan, Tara Hiltke, Xian Chen, Yingming Zhao, Yue Wang, Zhen Zhang - Cell 2019 被引用: 862

  6. MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation

    著者: Kyung‐min Lee, Jennifer M. Giltnane, Justin M. Balko, Luis J. Schwarz, Ángel Guerrero‐Zotano, Katherine E. Hutchinson, Mellissa J. Nixon, Mónica V. Estrada, Violeta Sánchez, Melinda E. Sanders, Taekyu Lee, Henry Gómez, Aňa Lluch, José Alejandro Pérez Fidalgo, Melissa M. Wolf, Gabriela Andrejeva, Jeffrey C. Rathmell, Stephen W. Fesik, Carlos L. Arteaga - Cell Metabolism 2017 被引用: 646

  7. Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy

    著者: Karsten Krug, Eric J. Jaehnig, Shankha Satpathy, Lili M. Blumenberg, Alla Y. Karpova, Meenakshi Anurag, George Miles, Philipp Mertins, Yifat Geffen, Lauren C. Tang, David I. Heiman, Song Cao, Yosef E. Maruvka, Jonathan T. Lei, Chen Huang, Ramani Kothadia, Antonio Colaprico, Chet Birger, Jarey H. Wang, Yongchao Dou, Bo Wen, Zhiao Shi, Yuxing Liao, Maciej Wiznerowicz, Matthew A. Wyczalkowski, Xi Chen, Jacob J. Kennedy, Amanda G. Paulovich, Mathangi Thiagarajan, Christopher R. Kinsinger, Tara Hiltke, Emily S. Boja, Mehdi Mesri, Ana I. Robles, Henry Rodriguez, Thomas F. Westbrook, Li Ding, Gad Getz, Karl R. Clauser, David Fenyö, Kelly V. Ruggles, Bing Zhang, D.R. Mani, Steven A. Carr, Matthew J. Ellis, Michael A. Gillette, Shayan C. Avanessian, Shuang Cai, Daniel Chan, Xian Chen, Nathan Edwards, Andrew N. Hoofnagle, M. Harry Kane, Karen A. Ketchum, Eric Kuhn, Douglas A. Levine, Shunqiang Li, D.C. Liebler, Tao Liu, Jingqin Luo, Subha Madhavan, Christopher G. Maher, Jason McDermott, Peter B. McGarvey, Mauricio Oberti, Akhilesh Pandey, Samuel Payne, David F. Ransohoff, Robert Rivers, Karin Rodland, Paul A. Rudnick, Melinda E. Sanders, Kenna M. Shaw, Ie‐Ming Shih, Robbert J.C. Slebos, Richard Smith, M Snyder, Stephen E. Stein, David L. Tabb, Ratna R. Thangudu, Stefani N. Thomas, Yue Wang, Forest M. White, Jeffrey R. Whiteaker, Gordon A. Whiteley, Hui Zhang, Zhen Zhang, Yingming Zhao, Heng Zhu, Lisa J. Zimmerman - Cell 2020 被引用: 575

  8. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer

    著者: Hui Zhang, Tao Liu, Zhen Zhang, Samuel Payne, Bai Zhang, Jason McDermott, Jianying Zhou, Vladislav Petyuk, Li Chen, Debjit Ray, Shisheng Sun, Feng Yang, Lijun Chen, Jing Wang, Punit Shah, Seong Won, Paul Aiyetan, Sunghee Woo, Yuan Tian, Marina A. Gritsenko, Therese RW Clauss, Caitlin H. Choi, Matthew Monroe, Stefani N. Thomas, Song Nie, Chaochao Wu, Ronald Moore, Kun‐Hsing Yu, David L. Tabb, David Fenyö, Vineet Bafna, Yue Wang, Henry Rodriguez, Emily S. Boja, Tara Hiltke, Robert Rivers, Lori J. Sokoll, Heng Zhu, Ie‐Ming Shih, Leslie Cope, Akhilesh Pandey, Bing Zhang, M Snyder, Douglas A. Levine, Richard Smith, Daniel W. Chan, Karin Rodland, Steven A. Carr, Michael A. Gillette, Karl R. Klauser, Eric Kuhn, D.R. Mani, Philipp Mertins, Karen A. Ketchum, Ratna R. Thangudu, Shuang Cai, Mauricio Oberti, Amanda G. Paulovich, Jeffrey R. Whiteaker, Nathan Edwards, Peter B. McGarvey, Subha Madhavan, Pei Wang, Daniel W. Chan, Akhilesh Pandey, Ie‐Ming Shih, Hui Zhang, Zhen Zhang, Heng Zhu, Leslie Cope, Gordon A. Whiteley, Steven J. Skates, Forest M. White, Douglas A. Levine, Emily S. Boja, Christopher R. Kinsinger, Tara Hiltke, Mehdi Mesri, Robert Rivers, Henry Rodriguez, Kenna M. Shaw, Stephen E. Stein, David Fenyö, Tao Liu, Jason McDermott, Samuel Payne, Karin Rodland, Richard Smith, Paul A. Rudnick, M Snyder, Yingming Zhao, Xian Chen, David F. Ransohoff, Andrew N. Hoofnagle, D.C. Liebler, Melinda E. Sanders, Zhiao Shi, Robbert J.C. Slebos, David L. Tabb, Bing Zhang ほか 10 名 - Cell 2016 被引用: 1,126

  9. Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy

    著者: Douglas B. Johnson, Mónica V. Estrada, Roberto Salgado, Violeta Sánchez, Deon B. Doxie, Susan R. Opalenik, Anna E. Vilgelm, Emily Feld, Adam S. Johnson, Allison R. Greenplate, Melinda E. Sanders, Christine M. Lovly, Dennie T. Frederick, Mark C. Kelley, Ann Richmond, Jonathan M. Irish, Yu Shyr, Ryan J. Sullivan, Igor Puzanov, Jeffrey A. Sosman, Justin M. Balko - Nature Communications 2016 被引用: 572

  10. Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes

    著者: Brian D. Lehmann, Antonio Colaprico, Tiago C. Silva, Jianjiao Chen, Hanbing An, Yuguang Ban, Hanchen Huang, Lily Wang, Jamaal L. James, Justin M. Balko, Paula I. González-Ericsson, Melinda E. Sanders, Bing Zhang, Jennifer A. Pietenpol, X. Steven Chen - Nature Communications 2021 被引用: 260

  11. Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research

    著者: Shona Hendry, Roberto Salgado, Thomas Gevaert, Prudence A. Russell, Tom John, Bibhusal Thapa, Michael Christie, Koen Van de Vijver, Mónica V. Estrada, Paula I. González-Ericsson, Melinda E. Sanders, Benjamin Solomon, Cinzia Solinas, Gert G. G. M. Van den Eynden, Yves Allory, Matthias Preusser, Johannes A. Hainfellner, Giancarlo Pruneri, Andrea Vingiani, Sandra Demaria, Fraser Symmans, Paolo Nucíforo, Laura Comerma, E. Aubrey Thompson, Sunil R. Lakhani, Seong-Rim Kim, Stuart J. Schnitt, Cécile Colpaert, Christos Sotiriou, Stefan Scherer, Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane B. Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André L. Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 被引用: 720

  12. DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer

    著者: Na Luo, Mellissa J. Nixon, Paula I. González-Ericsson, Violeta Sánchez, Susan R. Opalenik, Huili Li, Cynthia A. Zahnow, Michael L. Nickels, Fei Liu, Mohammed Noor Tantawy, Melinda E. Sanders, H. Charles Manning, Justin M. Balko - Nature Communications 2018 被引用: 271

  13. Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer

    著者: Luigi Formisano, Yao Lu, Alberto Servetto, Ariella B. Hanker, Valerie M. Jansen, Joshua A. Bauer, Dhivya R. Sudhan, Ángel Guerrero‐Zotano, Sarah Croessmann, Yan Guo, Paula I. González-Ericsson, Kyung‐min Lee, Mellissa J. Nixon, Luis J. Schwarz, Melinda E. Sanders, Teresa C. Dugger, Marcelo Cruz, Amir Behdad, Massimo Cristofanilli, Aditya Bardia, Joyce O’Shaughnessy, Rebecca J. Nagy, Richard B. Lanman, Nadia Solovieff, Wei He, Michelle C. Miller, Fei Su, Yu Shyr, Ingrid A. Mayer, Justin M. Balko, Carlos L. Arteaga - Nature Communications 2019 被引用: 419

  14. Limiting mitochondrial plasticity by targeting DRP1 induces metabolic reprogramming and reduces breast cancer brain metastases

    著者: Pravat Kumar Parida, Mauricio Marquez-Palencia, Suvranil Ghosh, Nitin Khandelwal, Kangsan Kim, Vidhya R. Nair, Xiao‐Zheng Liu, Hieu Vu, Lauren G. Zacharias, Paula I. González-Ericsson, Melinda E. Sanders, Bret C. Mobley, Jeffrey G. McDonald, Andrew Lemoff, Yan Peng, Cheryl Lewis, Gonçalo Vale, Nils Halberg, Carlos L. Arteaga, Ariella B. Hanker, Ralph J. DeBerardinis, Srinivas Malladi - Nature Cancer 2023 被引用: 92

  15. Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis

    著者: Susana García‐Recio, Toshinori Hinoue, Gregory Wheeler, Benjamin Kelly, Ana C. Garrido-Castro, Tomás Pascual, Aguirre A. de Cubas, Youli Xia, Brooke Felsheim, Marni B. McClure, Andrei Rajkovic, Ezgi Karaesmen, Markia A. Smith, Cheng Fan, Paula I. González-Ericsson, Melinda E. Sanders, Chad J. Creighton, Jay Bowen, Kristen Leraas, Robyn Burns, Sara E. Coppens, Amy Wheless, Salma Rezk, Amy Garrett, Joel S. Parker, Kelly K. Foy, Hui Shen, Ben Ho Park, Ian E. Krop, Carey K. Anders, Julie M. Gastier‐Foster, Mothaffar F. Rimawi, Rita Nanda, Nancy U. Lin, Claudine Isaacs, P. Kelly Marcom, Anna Maria Storniolo, Fergus J. Couch, Uma Chandran, Michael A. Davis, Jonathan C. Silverstein, Alexander J. Ropelewski, Minetta C. Liu, Susan G. Hilsenbeck, Larry Norton, Andrea L. Richardson, W. Fraser Symmans, Antonio C. Wolff, Nancy E. Davidson, Lisa A. Carey, Adrian V. Lee, Justin M. Balko, Katherine A. Hoadley, Peter W. Laird, Elaine R. Mardis, Tari A. King, AURORA US Network, Aguirre A. de Cubas, Charles M. Perou - Nature Cancer 2022 被引用: 114

  16. RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors

    著者: Sherene Loi, Sathana Dushyanthen, Paul A. Beavis, Roberto Salgado, Carsten Denkert, Peter Savas, S.E. Combs, David L. Rimm, Jennifer M. Giltnane, Mónica V. Estrada, Violeta Sánchez, Melinda E. Sanders, Rebecca S. Cook, Mark A. Pilkinton, S. Mallal, Kai Wang, Vincent A. Miller, Phil Stephens, Roman Yelensky, Franco D. Doimi, Henry Gómez, Sergey Ryzhov, Phillip K. Darcy, Carlos L. Arteaga, Justin M. Balko - Clinical Cancer Research 2015 被引用: 552

  17. TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer

    著者: Neil E. Bhola, Justin M. Balko, Teresa C. Dugger, M. Gabriela Kuba, Violeta Sánchez, Melinda E. Sanders, Jamie C. Stanford, Rebecca S. Cook, Carlos L. Arteaga - Journal of Clinical Investigation 2013 被引用: 593

  18. Metabolic diversity within breast cancer brain-tropic cells determines metastatic fitness

    著者: Pravat Kumar Parida, Mauricio Marquez-Palencia, Vidhya R. Nair, Akash Kaushik, Kangsan Kim, Jessica Sudderth, Eduardo Quesada-Diaz, Ámbar Cajigas, Vamsidhara Vemireddy, Paula I. González-Ericsson, Melinda E. Sanders, Bret C. Mobley, Kenneth E. Huffman, Sunati Sahoo, Prasanna Alluri, Cheryl Lewis, Yan Peng, Robert Bachoo, Carlos L. Arteaga, Ariella B. Hanker, Ralph J. DeBerardinis, Srinivas Malladi - Cell Metabolism 2022 被引用: 104

  19. Integrated Proteomic and Glycoproteomic Characterization of Human High-Grade Serous Ovarian Carcinoma

    著者: Yingwei Hu, Jianbo Pan, Punit Shah, Minghui Ao, Stefani N. Thomas, Yang Liu, Lijun Chen, Michael Schnaubelt, David Clark, Henry Rodriguez, Emily S. Boja, Tara Hiltke, Christopher R. Kinsinger, Karin Rodland, Qing Kay Li, Jiang Qian, Zhen Zhang, Daniel W. Chan, Hui Zhang, Akhilesh Pandey, Amanda G. Paulovich, Andrew N. Hoofnagle, Bing Zhang, D.R. Mani, D.C. Liebler, David F. Ransohoff, David Fenyö, David L. Tabb, Douglas A. Levine, Eric Kuhn, Forest M. White, Gordon A. Whiteley, Heng Zhu, Ie‐Ming Shih, Jasmin Bavarva, Jason McDermott, Jeffrey R. Whiteaker, Karen A. Ketchum, Karl R. Clauser, Kelly V. Ruggles, Kimberly Elburn, Li Ding, Linda I. Hannick, Lisa J. Zimmerman, Mark A. Watson, Mathangi Thiagarajan, Matthew J. Ellis, Mauricio Oberti, Mehdi Mesri, Melinda E. Sanders, Melissa Borucki, Michael A. Gillette, M Snyder, Nathan Edwards, Negin Vatanian, Paul A. Rudnick, Peter B. McGarvey, Philip Mertins, R. Reid Townsend, Ratna R. Thangudu, Richard Smith, Robert Rivers, Robert J.C. Slebos, Samuel Payne, Sherri R. Davies, Shuang Cai, Stephen E. Stein, Steven A. Carr, Steven J. Skates, Subha Madhavan, Tao Liu, Xian Chen, Yingming Zhao, Yue Wang, Zhiao Shi - Cell Reports 2020 被引用: 155

  20. TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR+ Metastatic Triple-Negative Breast Cancer

    著者: Brian D. Lehmann, Vandana G. Abramson, Melinda E. Sanders, Erica L. Mayer, Tufia C. Haddad, Rita Nanda, Catherine Van Poznak, Anna Maria Storniolo, Julie R. Nangia, Paula I. González-Ericsson, Violeta Sánchez, Kimberly N. Johnson, Richard G. Abramson, Sheau‐Chiann Chen, Yu Shyr, Carlos L. Arteaga, Antonio C. Wolff, Jennifer A. Pietenpol - Clinical Cancer Research 2019 被引用: 154

  21. NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer

    著者: Brandie C. Taylor, Xiaopeng Sun, Paula I. González-Ericsson, Violeta Sánchez, Melinda E. Sanders, Elizabeth C. Wescott, Susan R. Opalenik, Ann Hanna, Shu-Ting Chou, Luc Van Kaer, Henry Gómez, Claudine Isaacs, Tarah J. Ballinger, Cesar A. Santa‐Maria, Payal D. Shah, Elizabeth Claire Dees, Brian D. Lehmann, Vandana G. Abramson, Jennifer A. Pietenpol, Justin M. Balko - Cancer Discovery 2023 被引用: 63

  22. PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors

    著者: Brian D. Lehmann, Joshua A. Bauer, Johanna M. Schafer, Christopher S Pendleton, Luojia Tang, Kimberly C. Johnson, Xi Chen, Justin M. Balko, Henry Gómez, Carlos L. Arteaga, Gordon B. Mills, Melinda E. Sanders, Jennifer A. Pietenpol - Breast Cancer Research 2014 被引用: 331

  23. Quantitative Optical Imaging of Primary Tumor Organoid Metabolism Predicts Drug Response in Breast Cancer

    著者: Alex J. Walsh, Rebecca S. Cook, Melinda E. Sanders, Luigi Aurisicchio, Gennaro Ciliberto, Carlos L. Arteaga, Melissa C. Skala - Cancer Research 2014 被引用: 318

  24. Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagement

    著者: Douglas B. Johnson, Mellissa J. Nixon, Yu Wang, Daniel Wang, Emily Castellanos, Mónica V. Estrada, Paula I. González-Ericsson, Candace H. Cote, Roberto Salgado, Violeta Sánchez, Phillip T. Dean, Susan R. Opalenik, Daniel M. Schreeder, David L. Rimm, Ju‐Young Kim, Jennifer Bordeaux, Sherene Loi, Leora Horn, Melinda E. Sanders, P. Brent Ferrell, Yaomin Xu, Jeffrey A. Sosman, Randall S. Davis, Justin M. Balko - JCI Insight 2018 被引用: 159